share_log

Theravance Biopharma | SC TO-C: Written communication relating to an issuer or third party tender offer

Jul 14, 2022 06:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more